What we're reading, July 4, 2016: a hospital is offering free housing to get super-utilizers out of the emergency room; campaigns for patients to gain access to stem cell treatments are gaining momentum; and why hospital/physician integration and consolidation probably won't lower costs.
The University of Illinois Hospital is offering free housing for frequent users of the emergency room. The hospital is using $250,000 of its own money on a pilot to get patients who are considered “super-utilizers” out of the emergency room and into an apartment, reported NPR. The program provides 25 patients with an apartment and a case manager to help them schedule doctor’s appointments instead of using the emergency room. Instead of paying $3000 per day for hospital care, the hospital is only paying $1000 a month for an apartment.
Campaigns for patients to gain access to stem cell treatments are gaining momentum across the country. According to STAT, a bill was introduced in Washington, DC, for the FDA to grant conditional approval for stem cell treatments without data from Phase 3 trials, and a state agency in California is enlisting patients to push for the federal regulatory process to be sped up. However, critics warn that faster approvals could undermine the FDA’s authority. The FDA maintains that stem cell treatment for most conditions still remains “largely unproven.”
The hope that hospital/physician integration will lower healthcare expenses is probably wishful thinking, writes physician Peter Ubel, MD, in a piece for Forbes. While Medicare is encouraging consolidation into entities like accountable care organizations and integration similar to that of the Kaiser Permanente system, it could end up costing a lot of money when hospitals and physicians join forces. The primary reason physicians join hospitals is not to achieve greater efficiencies, but to give them greater negotiating power with insurers, which results in higher costs for patients.
Lack of Mutations Associated With Favorable Prognosis in MPN-U
April 25th 2024While the Dynamic International Prognostic Scoring System and bone marrow blasts may predict overall survival, the lack of certain mutations is also associated with a better prognosis for myeloproliferative neoplasm, unclassifiable (MPN-U).
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Data Back Neoadjuvant Combo vs Chemo Alone for Early-Stage NSCLC
April 24th 2024For patients with early-stage non–small cell lung cancer (NSCLC), combining neoadjuvant immune checkpoint inhibitors and platinum-based chemotherapy improves 2-year outcomes over chemotherapy alone, suggest findings of an extensive literature review and meta-analysis.
Read More